Galapagos, NovAliX join forces for integrated drug discovery

By NS Healthcare Staff Writer

31 Mar 23

Under the agreement, NovAliX will assume Galapagos’ research capabilities in Romainville, while the latter will retain the flexibility…

Patient CarePharmaceuticals and Medicines

Emergent’s NARCAN Nasal Spray gets FDA nod as OTC treatment for opioid overdose

By NS Healthcare Staff Writer

30 Mar 23

The prescription-to-OTC approval is backed by Human Factors study data, an updated Drug Facts label, pharmacovigilance data gathered…

Patient CarePharmaceuticals and Medicines

Bristol Myers Squibb secures EC approval for Sotyktu in plaque psoriasis

By NS Healthcare Staff Writer

29 Mar 23

The TYK2 inhibitor showed superior efficacy in improving skin clearance compared to placebo and twice-daily Otezla in the…

Patient CarePharmaceuticals and Medicines

Thermo Fisher opens new cell therapy facility at UCSF, California

By NS Healthcare Staff Writer

28 Mar 23

Built under the partnership between Thermo Fisher and UCSF, the facility will focus on cell therapies for difficult…

Patient CarePharmaceuticals and Medicines

AbbVie’s upadacitinib meets primary endpoint in phase 2 SLE study

By NS Healthcare Staff Writer

24 Mar 23

Based on the results of the mid-stage trial, the company is advancing the clinical programme of upadacitinib in…

Patient CarePharmaceuticals and Medicines

Cidara’s REZZAYO gets FDA approval for candidemia and invasive candidiasis

By NS Healthcare Staff Writer

23 Mar 23

The approval was based on clinical data from the global ReSTORE phase 3 trial and is also backed…

Patient CarePharmaceuticals and Medicines

Amgen to slash 450 jobs amid drug pricing pressure and inflation

By NS Healthcare Staff Writer

20 Mar 23

Accounting for less than 2% of its total global workforce of over 25,000, the latest move is Amgen’s…

Patient CarePharmaceuticals and Medicines

Eris Lifesciences to acquire dermatology brands from Dr Reddy’s for $33m

By NS Healthcare Staff Writer

17 Mar 23

The dermatology brands sold by Dr. Reddy's to Eris Lifesciences include Hydroheal, Revilus, Avarta, Aquaderm, and others

Patient CarePharmaceuticals and Medicines

Janssen’s dengue antiviral JNJ-1802 shows efficacy in pre-clinical data

By NS Healthcare Staff Writer

16 Mar 23

The antiviral is now going into phase 2 clinical studies for both the prevention and treatment of dengue

Patient CarePharmaceuticals and Medicines

Pfizer to acquire American biotech company Seagen for $43bn

By NS Healthcare Staff Writer

14 Mar 23

The deal is expected to allow for combining potential across the pipelines of both firms and will make…

Patient CarePharmaceuticals and Medicines